Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

Technology appraisal guidance
Reference number: TA341
Published: 04 June 2015

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document

Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - apixaban [ID726]: final appraisal determination document
06 March 2015
(384.84 Kb 52 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 04 March 2015